Stay updated on Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision label was updated from **v3.5.0** to **v3.5.3**, reflecting a site/record version change without altering the displayed study details.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 replaces the previous v3.4.1 label on the page. No substantive changes to study details or criteria are observed.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.1 replaces the previous Revision: v3.4.0 on the page; this is a minor metadata update with no impact on study data or functionality, and to avoid alerts from small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Trabectedin in Soft Tissue Sarcomas Clinical Trial page.